Surface Ophthalmics
Kam Hoss, MD, PhD has a diverse range of work experience in the field of ophthalmology and healthcare entrepreneurship. Starting in 2000, they worked as an Assistant Professor and Research Fellow in Ophthalmology at UTMB. From 2003 to 2005, they served as a Post Doc Fellow at UCSF Medical Center. Following this, they joined Johnson & Johnson / ALZA as the Director of Ophthalmology from 2005 to 2007. In 2008, Dr. Hoss co-founded InSite Vision, Inc., where they held the roles of Site Lead and Chief Medical Officer until 2017. Kam also co-founded KMG Pharma in 2008 and served as the Chief Medical Officer. Currently, they are the co-founder and CEO of Surface Ophthalmics, Inc., a company they established in 2018.
Kam Hoss, MD, PhD's education history is not provided.
This person is not in any teams
Surface Ophthalmics
Surface Ophthalmics is a pharmaceutical company that develops therapeutics for the treatment of ocular diseases. The company's current drug pipeline consists of three proprietary drug candidates, all utilizing Klarity, a patented delivery vehicle.Surface Ophthalmics was founded in 2017 and is based in Pleasanton, California.